Author:

Jacob Taylor

HHS Makes Adjustments to SUD Part 2 Requirements

Aaron O’Neill Associate Editor Loyola University Chicago School of Law, JD 2024 On February 8, the Department of Health and Human Services (HHS) posted its new final rule to align 42 CFR Part 2 with HIPAA regulations, which will improve coordination of care for substance use disorder (SUD) patients and improve privacy protections. The new …
Read more

Right to Try Risks

Delaney Szwed   Associate Editor   Loyola University Chicago School of Law, JD 2024  When it comes to the regulation of a treatment option intended for individuals diagnosed with life threatening diseases, one may think that the Food and Drug Administration (FDA) is heavily involved. However, this is not the case under the Right to Try Act, which …
Read more

The Missing Oversight of Tesla and Elon Musk

Anokhi Manchanda Associate Editor Loyola University Chicago School of Law, JD 2025 Although Tesla is a power player in electric vehicles, there have recently been concerns after its $94 billion drop in market valuation at the beginning of 2024. For a company with a $750 billion valuation, that can be worrisome. However, there are bigger concerns when it comes …
Read more

Byte-Size Privacy Concerns: Navigating the Health Implications of Digital

Kirsten Brueggemann Associate Editor Loyola University Chicago School of Law, JD 2025 The U.S. is tightening its regulation of online tracking technology, especially in relation to protected health information (PHI). The enforcement of the Health Insurance Portability and Accountability Act (HIPAA) falls under the jurisdiction of the Office of Civil Rights (OCR), which is part …
Read more

Is Meta the ultimate drug dealer?

Katherine O’Malley Associate Editor Loyola University Chicago School of Law, 2025 Only two countries in the world allow direct to consumers advertisements for pharmaceutical drugs: United States of America and New Zealand. The United States is currently facing a drug overdose epidemic, promoting both the FDA and DEA to intensify efforts to combat misleading  dangerous drug advertisements. …
Read more

Breakthrough for Psychedelic Drugs as LSD moves closer to FDA approval.

Doria Keys Associate Editor Loyola University Chicago School of Law, JD 2025   Anxiety disorders are among the most common mental illnesses diagnosed in the United States. Specifically, General Anxiety Disorder (GAD) manifests as persistent and exaggerated worry about a number of different things in life, including, but not limited to, finances, health, family, and …
Read more

Side-Hustles: Harmless Earning or Compliance Nightmare?

Sean McBride Associate Editor Loyola University Chicago School of Law, JD 2025 Younger employees have been increasingly engaging in side-businesses or “side-hustles” to earn extra income. This once innocently perceived practice has become a substantial compliance risk for employers and individuals who may not realize they are falling out of compliance with Internal Revenue Service …
Read more

Messaging Rates Apply: US Bank NA and Oppenheimer & Co. to Pay CFTC $7 Million

Jossie Ward  Associate Editor Loyola University Chicago School of Law, JD 2025 The U.S. Commodity Futures Trading Commission (CFTC) regulates U.S. derivative markets, including futures, options, and swaps. On March 19, 2024, the CFTC announced that the independent agency has reached an agreement with U.S. Bank National Association (U.S. Bank NA) and Oppenheimer & Co. …
Read more

The Environment’s Impact on Trading Methods: The Panama Canal

Noor Abdelfattah Associate Editor  Loyola University Chicago School of Law, JD 2025 As  environmental crises are on the rise, in addition to harming the livelihood of some of the most vulnerable in the world, their consequences are leading to disasters costing trillions of dollars over time. More recently, Panama, situated in Central America, and known for its rainfall and …
Read more

The GDPR Dilemma: Personalization and Privacy

André MooreAssociate EditorLoyola University Chicago School of Law, JD ‘25 The digital marketing world is constantly changing, and the European Union’s implementation of the General Data Protection Regulation (GDPR) in May 2018 has significantly changed how personal data is used for marketing purposes. This new regulation aims to give individuals greater control over their personal data …
Read more